Table 3.
Effect of Pluchea lanceolata (PL) on phagocytic function of murine macrophages
Treatment(Dose μg/ml) | % Phagocytosis (in vitro study) mean ± S.E. | Treatment (dose mg/kg) | Phagocytic Index (in vivo study) (Mean ± S.E.) | ||
---|---|---|---|---|---|
Naïve Control | 25.23 ± 1.26 | - | Sensitized Control | 1.28 ± 0.12 | - |
Cyclosporine-A(10) | 13.76 ± 0.33** | (45.46) ↓ | Cyclosporine-A(5) | 0.69 ± 0.10** | (46.09) ↓ |
PL (50) | 24.12 ± 1.33 | (4.39) ↓ | PL (50) | 1.24 ± 0.14 | (3.12) ↓ |
PL (100) | 22.48 ± 0.92 | (10.89) ↓ | PL (100) | 1.20 ± 0.10 | (6.25) ↓ |
PL (200) | 21.79 ± 0.75* | (13.63) ↓ | PL (200) | 1.12 ± 0.12* | (12.50) ↓ |
PL (400) | 19.80 ± 0.75** | (21.52) ↓ | PL (400) | 1.00 ± 0.10** | (21.87) ↓ |
PL (600) | 17.35 ± 0.59** | (31.23) ↓ | PL (600) | 0.84 ± 0.12** | (44.53) ↓ |
PL (800) | 18.26 ± 0.39** | (27.62) ↓ | PL (800) | 0.83 ± 0.14** | (45.31) ↓ |
P < 0.05;
P < 0.01 (Dunnett test, which compares test groups and the standard drug group with the control group); Figures in parentheses represent percent change in activity; number of animals per group = 6